Larry Whitfield is an Endocrinology/Metabolic physician. OpenAlex indexes 5 publications with 420 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
5012 S Us Highway 75
Suite 300
Denison, TX 750204587
Telephone
903-416-6010Registry record last updated 26 Jan 2018.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year20222 payments
- Insulet CorporationProgram year20221 payment
- Ultragenyx Pharmaceutical Inc.Program year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
41.2%Statin12%Atorvastatin Calcium45%Rosuvastatin Calcium45%Simvastatin11%Part D<11 patientsAngiotensin receptor blocker (ARB)11%Losartan Potassium26%Irbesartan24%Valsartan-Hydrochlorothiazide19%Valsartan12%Losartan-Hydrochlorothiazide10%Irbesartan-Hydrochlorothiazide9%Part D<11 patients+ 6 more classes in this area
Metabolism & gastrointestinal
33.4%Biguanide (metformin)7.9%Metformin Hcl100%Part D≥48 patientsSGLT2 inhibitor6.4%Jardiance65%Farxiga35%Part D<11 patients+ 7 more classes in this area
Hormonal (systemic)
14.3%l-Thyroxine14.3%Levothyroxine Sodium90%Synthroid10%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Reductions in plasma catecholamines and blood pressure during weight loss in obese subjects
European Journal of Endocrinology
1983 - Role of the Sympathetic Nervous System in Blood Pressure Maintenance in Obesity
The Journal of Clinical Endocrinology & Metabolism
1982 - Dopaminergic Control of Plasma Catecholamine and Aldosterone Responses to Acute Stimuli in Normal Man
The Journal of Clinical Endocrinology & Metabolism
1980
Similar KOLs
Other experts from the same institution or the same specialty.
Bruce Bartholow Duncan
Universidade Federal do Rio Grande do Sul
Alireza Esteghamati
Tehran University of Medical Sciences
Paul Zimmet
Monash University
André Pascal Kengne
South African Medical Research Council
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”